Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Waldemar Halota
Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Selenium, Glutathione and Glutathione Peroxidases in Blood of Patients With Chronic Liver Diseases.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Related publications
Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis
New England Journal of Medicine
Medicine
Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study
Hepatology
Medicine
Hepatology
Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil
Cost Effectiveness and Resource Allocation
Health Policy
PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a
Virology Journal
Virology
Infectious Diseases
Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response
PLoS ONE
Multidisciplinary
Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
Gastroenterology
Hepatology
Gastroenterology
Clinical Predictors for Neutrophil–to–Lymphocyte Ratio Changes in Patients With Chronic Hepatitis B Receiving Peginterferon Treatment
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
